Focalin Capsule, Extended Release
Pricing Report NDC 0078-0609-05

Latest NADAC: $5.42512 per EA · Effective Oct 22, 2025 · Est. package price $542.51 (100 EA)

Current Package Pricing Information

The latest wholesale acquisition cost for Focalin Xr (NDC 0078-0609-05) is $5.42512 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Oct 22, 2025.

As a a human prescription drug provided by Novartis Pharmaceuticals Corporation, this medication is distributed in a 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$5.42512
Per EA

Effective Date
Oct 22, 2025
Billable Units
100 EA
Estimated Package Price
$542.51
Data Status
As of Aug 19, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $2.09315 (Effective: Aug 19, 2026)
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2013, the NADAC wholesale price for (NDC ) has moved within a range of $5.42512 to $15.05421 per EA. Over this 12 years and 3 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$5.4251 - $15.0542
Market Volatility
177.49% Variance
Latest Trend
0.01%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Oct 22, 2025 $5.42512 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $5.42512 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Oct 22, 2025 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Oct 22, 2025 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Oct 22, 2025 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Oct 22, 2025 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Oct 22, 2025 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Oct 22, 2025 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Oct 22, 2025 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Oct 22, 2025 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Oct 22, 2025 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Sep 17, 2025 $5.42554 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026